Insmed Inc banner

Insmed Inc
F:IM8N

Watchlist Manager
Insmed Inc Logo
Insmed Inc
F:IM8N
Watchlist
Price: 91.19 EUR -0.88% Market Closed
Market Cap: €14.9B

Wall St Price Targets

IM8N Price Targets Summary
Insmed Inc

Wall Street analysts forecast IM8N stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IM8N is 246.86 EUR with a low forecast of 167 EUR and a high forecast of 301.34 EUR.

Lowest Forecast
Price Target
167 EUR
83% Upside
Average Forecast
Price Target
246.86 EUR
171% Upside
Highest Forecast
Price Target
301.34 EUR
230% Upside
Insmed Inc Competitors:
Price Targets
MTLS
Materialise NV
58% Upside
ISSC
Innovative Solutions and Support Inc
63% Upside

Revenue
Forecast

N/A
Past Growth
44% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
44% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

The compound annual growth rate for Revenue over the next 8 years is 44%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-62%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-62%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is IM8N's stock price target?
Price Target
246.86 EUR

According to Wall Street analysts, the average 1-year price target for IM8N is 246.86 EUR with a low forecast of 167 EUR and a high forecast of 301.34 EUR.

What is the Revenue forecast for Insmed Inc?
Projected CAGR
44%

The compound annual growth rate for Revenue over the next 8 years is 44%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett